Cite
HARVARD Citation
Li, Z. et al. (2016). Efficacy and safety results from a Phase 3, randomized, placebo‐controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. International journal of rheumatic diseases. pp. 1143-1156. [Online].